Clinical Trials Logo

Appendicitis Perforated clinical trials

View clinical trials related to Appendicitis Perforated.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03435900 Completed - Clinical trials for Appendicitis Perforated

Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis

Start date: February 14, 2018
Phase: Phase 2
Study type: Interventional

The objective of this trial is to evaluate if intraoperative intraperitoneal administration of fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by oral antibiotic for three days is as effective as the current intravenous antibiotic treatment given during and three days after appendectomy for perforated appendicitis. The primary outcome is the total length of hospital stay, defined as the number of hours in hospital after end of operation and until 30-day follow-up.